Fractional flow reserve (FFR) as a guide to treat coronary artery disease

References

• Authors/Task FM, Windecker S, Kolh P, et al. ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;2014(35):2541–2619.
   Google Scholar
• Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–1516.
   PubMed Web of Science ®Google Scholar
• Metz LD, Beattie M, Hom R, et al. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol. 2007;49:227–237.
   PubMed Web of Science ®Google Scholar
• Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenoses. N Engl J Med. 1996;334:1703–1708.
   PubMed Web of Science ®Google Scholar
• De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI vs. medical therapy in stable coronary disease. N Engl J Med. 2012;367:991–1001.
   PubMed Web of Science ®Google Scholar
• Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213–224.
   PubMed Web of Science ®Google Scholar
• Kern MJ. Coronary physiology revisited: practical insights from the cardiac catheterization laboratory. Circulation. 2000;101:1344–1351.
   PubMed Web of Science ®Google Scholar
• Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol. 1990;15:459–474.
   PubMed Web of Science ®Google Scholar
• Díez-Delhoyo F, Gutiérrez-Ibañes E, Loughlin G, et al. Coronary physiology assessment in the catheterization laboratory. World J Cardiol. 2015;7:525–538.
   PubMed Web of Science ®Google Scholar
• Mangiacapra F, Peace AJ, Di Serafino L, et al. Intracoronary enalaprilat to reduce microvascular damage during Percutaneous Coronary Intervention (ProMicro) study. J Am Coll Cardiol. 2013;61:615–621.
   PubMed Web of Science ®Google Scholar
• Mangiacapra F, Di Gioia G, Pellicano M, et al. Effects of prasugrel versus clopidogrel on coronary microvascular function in patients undergoing elective PCI. J Am Coll Cardiol. 2016;68:235–237.
   PubMed Web of Science ®Google Scholar
• Pyxaras SA, Tu S, Barbato E, et al. Quantitative angiography and optical coherence tomography for the functional assessment of nonobstructive coronary stenoses: comparison with fractional flow reserve. Am Heart J. 2013;166:1010–1018.e1.
   PubMed Web of Science ®Google Scholar
• Watkins S, McGeoch R, Lyne J, et al. Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease. Circulation. 2009;120:2207–2213.
   PubMed Web of Science ®Google Scholar
• Melikian N, De Bondt P, Tonino P, et al. Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease. JACC Cardiovasc Interv. 2010;3:307–314.
   PubMed Web of Science ®Google Scholar
• De Bruyne B, Pijls NH, Bartunek J, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation. 2001;104:157–162.
   PubMed Web of Science ®Google Scholar
• Toth GG, De Bruyne B, Rusinaru D, et al. impact of right atrial pressure on fractional flow reserve measurements: comparison of fractional flow reserve and myocardial fractional flow reserve in 1,600 coronary stenoses. JACC Cardiovasc Interv. 2016;9:453–459.
   PubMed Web of Science ®Google Scholar
• Ihdayhid AR, Yong A, Harper R, et al. A practical guide for fractional flow reserve guided revascularisation. Heart Lung Circ. 2018;27:406–419.
   PubMed Web of Science ®Google Scholar
• Johnson NP, Johnson DT, Kirkeeide RL, et al. Repeatability of fractional flow reserve despite variations in systemic and coronary hemodynamics. JACC Cardiovasc Interv. 2015;8:1018–1027.
   PubMed Web of Science ®Google Scholar
• Fearon WF, Bornschein B, Tonino PA, et al. Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation. 2010;122:2545–2550.
   PubMed Web of Science ®Google Scholar
• Barbato E, Toth GG, Johnson NP, et al. A prospective natural history study of coronary atherosclerosis using fractional flow reserve. J Am Coll Cardiol. 2016 Nov 29;68(21):2247–2255.
   PubMed Web of Science ®Google Scholar
• Johnson NP, Tóth GG, Lai D, et al. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol. 2014 Oct 21;64(16):1641–1654.
   PubMed Web of Science ®Google Scholar
• Ciccarelli G, Barbato E, Toth GG, et al. Angiography versus hemodynamics to predict the natural history of coronary stenoses: a fame 2-substudy. Circulation. 2017;137:1475–1485.
   PubMed Web of Science ®Google Scholar
• Adjedj J, De Bruyne B, Flore V, et al. Significance of intermediate values of fractional flow reserve in patients with coronary artery disease. Circulation. 2016;133:502–508.
   PubMed Web of Science ®Google Scholar
• Leone AM, Porto I, De Caterina AR, et al. Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study. JACC Cardiovasc Interv. 2012;5:402–408.
   PubMed Web of Science ®Google Scholar
• Schlundt C, Bietau C, Klinghammer L, et al. Comparison of intracoronary versus intravenous administration of adenosine for measurement of coronary fractional flow reserve. Circ Cardiovasc Interv. 2015;8. pii: e001781.
   PubMed Web of Science ®Google Scholar
• Al Jaroudi W, Iskandrian AE. Regadenoson: a new myocardial stress agent. J Am Coll Cardiol. 2009;54:1123–1130.
   PubMed Web of Science ®Google Scholar
• Arumugham P, Figueredo VM, Patel PB, et al. Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flowreserve EuroIntervention. 2013;8:1166–1171.
   PubMed Web of Science ®Google Scholar
• Parham WA, Bouhasin A, Ciaramita JP, et al. Coronary hyperemic dose responses of intracoronary sodium nitroprusside. Circulation. 2004;109:1236–1243.
   PubMed Web of Science ®Google Scholar
• Jang HJ, Koo BK, Lee HS, et al. Safety and efficacy of a novel hyperaemic agent,intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory. Eur Heart J. 2013;34:2055–2062.
   PubMed Web of Science ®Google Scholar
• van der Voort PH, van Hagen E, Hendrix G, et al. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve. Cathet Cardiovasc Diagn. 1996;39:120–125.
   PubMedGoogle Scholar
• De Bruyne B, Pijls NH, Barbato E, et al. Intracoronary and intravenous adenosine 5ʹ-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation. 2003;107:1877–1883.
   PubMed Web of Science ®Google Scholar
• Berry C. van ’t Veer M, Witt N et al. VERIFY (Verification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice): a Multicenter Study in Consecutive Patients. J Am Coll Cardiol. 2013;61:1421–1427.
   PubMed Web of Science ®Google Scholar
• Park SJ, Kang SJ, Ahn JM, et al. Visual-functional mismatch between coronary angiography and fractional flow reserve. JACC Cardiovasc Interv. 2012;5:1029–1036.
   PubMed Web of Science ®Google Scholar
• Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010;55:2816–2821.
   PubMed Web of Science ®Google Scholar
• Shiono Y, Kubo T, Tanaka A, et al. Impact of myocardial supply area on the transstenotic hemodynamics as determined by fractional flow reserve. Catheter Cardiovasc Interv. 2014;84:406–413.
   PubMed Web of Science ®Google Scholar
• Bech GJ, De Bruyne B, Pijls NH, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103:2928–2934.
   PubMed Web of Science ®Google Scholar
• De Bruyne B, Fearon WF, Pijls NH, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med. 2014;371:1208–1217.
   PubMed Web of Science ®Google Scholar
• Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol. 2007;49:2105–2111.
   PubMed Web of Science ®Google Scholar
• Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional flow reserve versus angiography for multivessel evaluation) study. J Am Coll Cardiol. 2010;56:177–184.
   PubMed Web of Science ®Google Scholar
• Xaplanteris P, Fournier S, Pijls NHJ, et al. Five-year outcomes with pci guided by fractional flow reserve. N Engl J Med. 2018 May 22. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Fearon WF, Nishi T, De Bruyne B, et al. Clinical outcomes and cost-effectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: three-year follow-up of the fame 2 trial (fractional flow reserve versus angiography for multivessel evaluation). Circulation. 2018;137:480–487.
   PubMed Web of Science ®Google Scholar
• Toth G, Hamilos M, Pyxaras S, et al. Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. Eur Heart J. 2014;35:2831–2838.
   PubMed Web of Science ®Google Scholar
• Hamilos M, Muller O, Cuisset T, et al. Long-term clinical outcome after fractional flow reserve guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation. 2009;120:1505–1512.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the coronary artery bypass graft surgery trialists collaboration. Lancet. 1994;344:563–570.
   PubMed Web of Science ®Google Scholar
• Gao XF, Zhang YJ, Tian NL, et al. Stenting strategy for coronary artery bifurcation with drug-eluting stents: a meta-analysis of nine randomised trials and systematic review. EuroIntervention. 2014;10:561–569.
   PubMed Web of Science ®Google Scholar
• Koh JS, Koo BK, Kim JH, et al. Relationship between fractional flow reserve and angiographic and intravascular ultrasound parameters in ostial lesions: major epicardial vessel versus side branch ostial lesions. JACC Cardiovasc Interv. 2012;5:409–415.
   PubMed Web of Science ®Google Scholar
• Koo BK, De Bruyne B. FFR in bifurcation stenting: what have we learned. EuroIntervention. 2010;6 Suppl J:J94–8.
   PubMed Web of Science ®Google Scholar
• Koo BK, Kang HJ, Youn TJ, et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol. 2005;46:633–637.
   PubMed Web of Science ®Google Scholar
• Koo BK, Park KW, Kang HJ, et al. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. Eur Heart J. 2008;29:726–732.
   PubMed Web of Science ®Google Scholar
• Chen SL, Ye F, Zhang JJ, et al. Randomized comparison of ffr-guided and angiography-guided provisional stenting of true coronary bifurcation lesions: the dkcrush-vi trial. (Double kissing crush versus provisional stenting technique for treatment of coronary bifurcation lesions VI). JACC Cardiovasc Interv. 2015;8:536–546.
   PubMed Web of Science ®Google Scholar
• De Bruyne B, Pijls NH, Heyndrickx GR, et al. Pressure-derived fractional flow reserve to assess serial epicardial stenoses: theoretical basis and animal validation. Circulation. 2000;101:1840–1847.
   PubMed Web of Science ®Google Scholar
• Kim HL, Koo BK, Nam CW, et al. Clinical and physiological outcomes of fractional flow reserve-guided percutaneous coronary intervention in patients with serial stenoses within one coronary artery. JACC Cardiovasc Interv. 2012;5:1013–1018.
   PubMed Web of Science ®Google Scholar
• Aqel R, Zoghbi GJ, Hage F, et al. Hemodynamic evaluation of coronary artery bypass graft lesions using fractional flow reserve. Catheter Cardiovasc Interv. 2008;72:479–485.
   PubMed Web of Science ®Google Scholar
• Di Serafino L, De Bruyne B, Mangiacapra F, et al. Long-term clinical outcome after fractional flow reserve- versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts. Am Heart J. 2013;166:110–118.
   PubMed Web of Science ®Google Scholar
• Echavarría-Pinto M, van de Hoef TP, Serruys PW, et al. Facing the complexity of ischaemic heart disease with intracoronary pressure and flow measurements: beyond fractional flow reserve interrogation of the coronary circulation. Curr Opin Cardiol. 2014;29:564–570.
   PubMed Web of Science ®Google Scholar
• van Nunen LX, Zimmermann FM, Tonino PA, et al. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet. 2015;386:1853–1860.
   PubMed Web of Science ®Google Scholar
• Ntalianis A, Trana C, Muller O, et al. Effective radiation dose, time, and contrast medium to measure fractional flow reserve. JACC Cardiovasc Interv. 2010;3:821–827.
   PubMed Web of Science ®Google Scholar
• Bax M, de Winter RJ, Koch KT, et al. Time course of microvascular resistance of the infarct and noninfarct coronary artery following an anterior wall acute myocardial infarction. Am J Cardiol. 2006;97:1131–1136.
   PubMed Web of Science ®Google Scholar
• Cuculi F, De Maria GL, Meier P, et al. Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014;64:1894–1904.
   PubMed Web of Science ®Google Scholar
• Marques KM, Knaapen P, Boellaard R, et al. Microvascular function in viable myocardium after chronic infarction does not influence fractional flow reserve measurements. J Nucl Med. 2007;48:1987–1992.
   PubMed Web of Science ®Google Scholar
• Hoebers LP, Vis MM, Claessen BE, et al. The impact of multivessel disease with and without a co-existing chronic total occlusion on short- and long-term mortality in ST-elevation myocardial infarction patients with and without cardiogenic shock. Eur J Heart Fail. 2013;15:425–432.
   PubMed Web of Science ®Google Scholar
• Engstrøm T, Kelbæk H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386:665–671.
   PubMed Web of Science ®Google Scholar
• Ntalianis A, Sels JW, Davidavicius G, et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2010;3:1274–1281.
   PubMed Web of Science ®Google Scholar
• Smits PC, Abdel-Wahab M, Neumann FJ, et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376:1234–1244.
   PubMed Web of Science ®Google Scholar
• Sels JW, Tonino PA, Siebert U, et al. Fractional flow reserve in unstable angina and non-ST segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. JACC Cardiovasc Interv. 2011;4:1183–1189.
   PubMed Web of Science ®Google Scholar
• Layland J, Oldroyd KG, Curzen N, et al. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. Eur Heart J. 2015;36:100–111.
   PubMed Web of Science ®Google Scholar
• Bainey KR, Mehta SR, Lai T, et al. Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis. Am Heart J. 2014;167:1–14.e2.
   PubMed Web of Science ®Google Scholar
• Nam CW, Hur SH, Cho YK, et al. Relation of fractional flow reserve after drug-eluting stent implantation to one-year outcomes. Am J Cardiol. 2011;107:1763–1767.
   PubMed Web of Science ®Google Scholar
• Pijls NH, Klauss V, Siebert U, et al. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002;105:2950–2954.
   PubMed Web of Science ®Google Scholar
• Buono F, Spinelli L, Giallauria F, et al. Usefulness of satisfactory control of low-density lipoprotein cholesterol to predict left ventricular remodeling after a first ST-elevation myocardial infarction successfully reperfused. Am J Cardiol. 2011;107:1772–1778.
   PubMed Web of Science ®Google Scholar
• Agarwal SK, Kasula S, Hacioglu Y, et al. Utilizing post-intervention fractional flow reserve to optimize acute results and the relationship to long-term outcomes. JACC Cardiovasc Interv. 2016;9:1022–1031.
   PubMed Web of Science ®Google Scholar
• Rimac G, Fearon WF, De Bruyne B, et al. Clinical value of post-percutaneous coronary intervention fractional flow reserve value: A systematic review and meta-analysis. Am Heart J. 2017;183:1–9.
   PubMed Web of Science ®Google Scholar
• Di Gioia G, Scarsini R, Strisciuglio T, et al. Correlation between angiographic and physiologic evaluation of coronary artery narrowings in patients with aortic valve stenosis. Am J Cardiol. 2017 Jul 1;120(1):106–110.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Tonino PA, De Bruyne B, et al. The impact of left ventricular ejection fraction on fractional flow reserve: insights from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) trial. Int J Cardiol. 2016 Feb;1(204):206–210.
   Web of Science ®Google Scholar
• Sen S, Escaned J, Malik IS, et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol. 2012;59:1392–1402.
   PubMed Web of Science ®Google Scholar
• Escaned J, Echavarría-Pinto M, Garcia-Garcia HM, et al. Prospective assessment of the diagnostic accuracy of instantaneous wave-free ratio to assess coronary stenosis relevance: results of advise ii international, multicenter study (adenosine vasodilator independent stenosis evaluation II). JACC Cardiovasc Interv. 2015;8:824–833.
   PubMed Web of Science ®Google Scholar
• Davies JE, Sen S, Dehbi HM, et al. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med. 2017;376:1824–1834.
   PubMed Web of Science ®Google Scholar
• Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med. 2017;376:1813–1823.
   PubMed Web of Science ®Google Scholar
• Jeremias A, Maehara A, Généreux P, et al. Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study. J Am Coll Cardiol. 2014;63:1253–1261.
   PubMed Web of Science ®Google Scholar
• Van’t Veer M, Pijls NHJ, Hennigan B, et al. Comparison of different diastolic resting indexes to ifr: are they all equal? J Am Coll Cardiol. 2017;70:3088–3096.
   PubMed Web of Science ®Google Scholar
• Berry C, van ‘t Veer M, Witt N, et al. VERIFY (VERification of Instantaneous Wave-free ratio and fractional flow reserve for the assessment of coronary artery stenosis severity in everyday practice): a multicenter study in consecutive patients. J Am Coll Cardiol. 2013 Apr 2;61(13):1421–1427.
   PubMed Web of Science ®Google Scholar
• Leone AM, Cialdella P, Martin-Reyes R, et al. cFFR as an alternative to FFR: please do not contrast simplicity. EuroIntervention. 2017;13:e1487–88.
   PubMed Web of Science ®Google Scholar
• Johnson NP, Jeremias A, Zimmermann FM, et al. Continuum of vasodilator stress from rest to contrast medium to adenosine hyperemia for fractional flow reserve assessment. JACC Cardiovasc Interv. 2016;9:757–767.
   PubMed Web of Science ®Google Scholar
• Tu S, Westra J, Yang J, et al. Diagnostic accuracy of fast computational approaches to derive fractional flow reserve from diagnostic coronary angiography: the international multicenter favor pilot study. Cir JACC Cardiovasc Interv. 2016;9:2024–2035.
   PubMed Web of Science ®Google Scholar
• Koo BK, Erglis A, Doh JH, et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol. 2011;58:1989–1997.
   PubMed Web of Science ®Google Scholar
• Nørgaard BL, Leipsic J, Gaur S, et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (analysis of coronary blood flow using ct angiography: next steps). J Am Coll Cardiol. 2014;63:1145–1155.
   PubMed Web of Science ®Google Scholar
• Patel MR Calhoon JH Dehmer GJ et al.; ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS2017. Appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the american college of cardiology appropriate use criteria task force, american association for thoracic surgery, american heart association, american society of echocardiography, american society of nuclear cardiology, society for cardiovascular angiography and interventions, society of cardiovascular computed tomography, and society of thoracic surgeons. J Am Coll Cardiol. 2017;69:2212–2241.
   PubMed Web of Science ®Google Scholar
• Toth GG, Toth B, Johnson NP, et al. Revascularization decisions in patients with stable angina and intermediate lesions: results of the international survey on interventional strategy. Circ Cardiovasc Interv. 2015;8:e002296.
   PubMed Web of Science ®Google Scholar
• Petraco R, Park JJ, Sen S, et al. Hybrid iFR-FFR decision-making strategy: implications for enhancing universal adoption of physiology-guided coronary revascularisation. EuroIntervention. 2013;8:1157–1165.
   PubMed Web of Science ®Google Scholar
• Rivero F, Cuesta J, Bastante T, et al. Diagnostic accuracy of a hybrid approach of instantaneous wave-free ratio and fractional flow reserve using high-dose intracoronary adenosine to characterize intermediate coronary lesions: results of the PALS (Practical Assessment of Lesion Severity) prospective study. Catheter Cardiovasc Interv. 2017;90:1070–1076.
   PubMed Web of Science ®Google Scholar
• Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391:31–40.
   PubMed Web of Science ®Google Scholar
• Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961–972.
   PubMed Web of Science ®Google Scholar
• Zimmermann FM, De Bruyne B, Pijls NH, et al. Rationale and design of the fractional flow reserve versus angiography for multivessel evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. Am Heart J. 2015;170:619–626.
   PubMed Web of Science ®Google Scholar